Faruqi Faruqi, LLP Investigates Semler Scientific for Alleged Securities Violations

What's Happening?

Faruqi & Faruqi, LLP, a national securities law firm, is investigating potential claims against Semler Scientific, Inc. The investigation focuses on allegations that the company and its executives violated federal securities laws by making false or misleading statements and failing to disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act. The firm has reminded investors of the October 28, 2025 deadline to seek the role of lead plaintiff in a federal securities class action filed against the company. The complaint alleges that Semler Scientific's public statements were materially false and misleading, particularly regarding the DOJ's investigation. Following the disclosure of initial settlement discussions with the DOJ, Semler Scientific's stock fell over 9%.

Why It's Important?

This investigation is significant as it highlights potential legal and financial repercussions for Semler Scientific, which could impact its stock value and investor confidence. The allegations of misleading statements and nondisclosure of a DOJ investigation could lead to substantial financial liabilities if the company is found guilty of violating securities laws. Investors who suffered losses may seek compensation, and the outcome of this case could set a precedent for how similar cases are handled in the future. The situation underscores the importance of transparency and compliance with federal regulations for publicly traded companies.

What's Next?

Investors have until October 28, 2025, to seek the role of lead plaintiff in the class action lawsuit. The court will appoint a lead plaintiff who has the largest financial interest and is typical of class members. This individual will direct and oversee the litigation on behalf of the class. The outcome of the lawsuit could result in financial restitution for affected investors. Additionally, the DOJ may decide to file a complaint or intervene in a civil False Claims Act lawsuit, which could further impact Semler Scientific's legal and financial standing.